HOUSTON, April 28, 2020 /PRNewswire-PRWeb/ -- Lex Mundi, in conjunction with members of the Lex Mundi Litigation, Arbitration and Dispute Resolution Group, has published the first-of-its kind interactive guide - Lex Mundi Global Attorney-Client Privilege Guide. This one-of-a kind guide allows users to compare common and civil law attorney-client privilege information for more than 65 jurisdictions around the world -- all in a side-by-side customized report.
Attorney-client privilege differs significantly between states and countries and also between common and civil law jurisdictions. Some civil law jurisdictions do not recognize the privilege but instead protect the information through professional ethics rules or otherwise. At a time of global financial crisis, when companies are struggling to maintain operations and solvency in the wake of supply chain disruption and demand side collapse, companies know that litigation is looming. Now, more than ever, it is important for companies and their counsel to take steps to protect privileged information in anticipation of the litigation to come.
The Lex Mundi Attorney-Client Privilege Guide details what constitutes attorney-client privilege in common and civil law jurisdictions around the world. Specific topics addressed in the guide include:
Lex Mundi created the guide with the help of Jenner & Block LLP, Lex Mundi member firm for USA, Illinois. David Greenwald, partner with Jenner & Block LLP, explained, "Our goal in creating this guide is to enable counsel and their clients to identify key differences among jurisdictions' laws and to provide citations to primary sources for further research." He added, "The law of privilege, and the differences between jurisdictions, is often misunderstood. This guide provides ready access to this important information."
The guide's interactive and innovative format allows users to search for and download an individual jurisdiction's report or compare multiple jurisdictions in a side-by-side customizable report. The Lex Mundi Attorney-Client Privilege Guide can be accessed free of charge on the Lex Mundi website at: https://www.lexmundi.com/lexmundi/Attorney-Client_Privilege_Guide.asp.
About Lex Mundi Lex Mundi is the world's leading network of independent law firms delivering consistent, high-quality advice that is critical to solving complex cross-border challenges. Our carefully vetted, and continuously reviewed, top-tier member firms uphold the highest-level service standards while offering preferred access to more than 22,000+ lawyers worldwide in more than 125 countries. Supported by client-focused methods, innovative technologies, joint learning and training, member firms collaborate across borders and industries to deliver joined-up solutions focused on real business results for clients.
Through our innovative service delivery model, clients have the ability to assemble an ideal international legal team, with the best lawyers in the jurisdictions that match their unique footprint, flexed to their most significant legal challenges.
Lex Mundi member law firms are located throughout Europe, the Middle East, Africa, Asia and the Pacific, Latin America and the Caribbean and North America. Through our nonprofit affiliate, the Lex Mundi Pro Bono Foundation, our members also provide pro bono legal assistance to social entrepreneurs around the globe.
For more information, please visit http://www.lexmundi.com and http://www.lexmundiprobono.org.
LONDON, April 24, 2020 /PRNewswire/ -- AxiaFunder, the UK's first for-profit litigation funding platform, today announces its second case win, returning 93.75% to investors in just 15 months.
The breach of contract case, which was funded in February 2019, raised £12,000 to enforce an adjudication award against a property developer. The case was favourably settled following a three-party mediation.
It comes after AxiaFunder's first case win produced a 43.00% return in only eight months with no losses to date.
Cormac Leech, CEO and Founder of AxiaFunder, said: "We are pleased to announce our second case win, which has produced solid returns to our investors through an Innovative Finance ISA eligible bond which was 83% principal protected via insurance. Despite market volatility in the wake of COVID-19, litigation funding offers retail and institutional investors an opportunity to diversify their investment portfolio. Unlike equities, litigation funding is uncorrelated to financial markets and the economy, continuing to generate healthy returns to investors while many other assets classes are underperforming in the current economic climate."
AxiaFunder has a strong pipeline of vetted cases that will be launched over the coming weeks. The first of which is the relaunch of a pre-vetted case backing a 'Francovich' claim – an action seeking damages against a Member State for breaching EU law. The VAT dispute claim is being relaunched to reflect a recent unexpected strike-out application during the funding process. AxiaFunder expects a net 5.5x multiple on investor capital if the case wins at trial, which is expected in around 18 months. Risk Warning: Capital at risk and returns not guaranteed.
Despite COVID-19 and the resulting economic headwinds, AxiaFunder's latest investment opportunity – a portfolio of three commercial litigation cases – was fully funded less than 24 hours after the launch of its marketing campaign.
Leech added: "The litigation funding market is expected to grow as COVID-19 increases insolvency litigation. As the UK's first for-profit litigation funding platform, AxiaFunder is well placed to provide access to capital for many of Britain's SMEs, who would otherwise struggle to afford the cost of litigation.
"AxiaFunder takes a stringent approach to vetting cases and only invests in those that have an estimated probability of a favourable outcome for investors of at least 70%. The vast majority of cases settle before trial with AxiaFunder's investors typically getting paid before the claimant which improves returns."
AxiaFunder itself recently closed an equity round raising over £250,000 of working capital, some of which was raised through Seedrs, the equity crowdfunding platform.
To date AxiaFunder has in total raised £775,000 of litigation funding for 6 commercial cases.
About AxiaFunder
Launched in November 2018, AxiaFunder (an appointed representative Share In Ltd) which is authorised and regulated by the Financial Conduct Authority (FRN 603332) enables both retail and institutional investors to provide funding to claimants who cannot afford to pay for their legal disputes. Investors receive a return on their capital if the case wins, however should note that Capital is at risk and returns are not guaranteed.
SAN CARLOS, Calif., April 14, 2020 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported it has entered into an agreement for litigation financing which has been filed today with the Securities and Exchange Commission on Form 8-K.
BioCardia, Inc. entered into a Litigation Funding Agreement with BSLF, L.L.C., an entity owned and controlled by Andrew Blank, a member of BioCardia’s board of directors, for the purpose of funding the Company’s currently pending legal proceedings and any and all claims, actions and/or proceedings relating to, or arising from, the case captioned Boston Scientific Corp., et al., v. BioCardia Inc., Case No. 3:19-05645-VC, U.S.D.C., N. D. Cal (the “Litigation”). The Litigation relates to matters the Company raised in a letter to Ms. Surbhi Sarna, nVision Medical and Boston Scientific based on BioCardia’s discovery in January 2019 that Ms. Sarna had assigned to a company she founded, nVision Medical, a patent and patent applications she had filed while a BioCardia employee. nVision subsequently was acquired by Boston Scientific.
BioCardia made various claims, including that the patent and patent application rightfully belonged to BioCardia pursuant to Ms. Sarna’s invention assignment agreement, that the proceeds from the sale of nVision to Boston Scientific rightfully belonged to BioCardia because they were the direct result of Ms. Sarna’s breach of her obligation to assign to BioCardia the patent and patent applications and the use of misappropriated BioCardia trade secrets. On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed Inc., and Fortis Advisors LLC (the “Boston Scientific Parties”) filed a complaint against BioCardia in the United States District Court Northern District of California, Case no. 3:19-05645-VC, seeking declarations that the claims made in BioCardia’s correspondence were without basis. On October 31, 2019, BioCardia filed a counterclaim against the Boston Scientific Parties and Ms. Sarna for breach of contract, misappropriation of trade secrets and correction of inventorship on the patents naming Ms. Sarna as an inventor. BioCardia seeks imposition of constructive trusts both on the patents naming Ms. Sarna as an inventor and the proceeds received from the sale of nVision to Boston Scientific, as well as damages, including unjust enrichment damages measured by the proceeds received from the sale of nVision to Boston Scientific.
Under the terms of the Funding Agreement, the Funder agreed to fund the legal fees and costs incurred by the Company in connection with the Litigation on and after March 1, 2020 on a non-recourse basis in return for a share of the litigation proceeds. Details of the Funding Agreement are available in the Form 8-K filed today.
BioCardia CEO Peter Altman, PhD, said, “This litigation financing gives BioCardia the wherewithal to pursue its claims in court. This preserves our investment focus on advancing our important cell therapy product pipeline to treat cardiovascular diseases, and the commercialization of our FDA-approved enabling device products.”
About BioCardia® BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular disease. CardiAMP™ and CardiALLO™ cell therapies are the Company’s biotherapeutic product candidates in clinical development. The Company's current products include the Helix™ transendocardial delivery system, the Morph® steerable guide and sheath catheter portfolio and the AVANCE™ steerable introducer family. BioCardia also partners with other biotherapeutic companies to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. Forward Looking Statements This press release contains forward-looking statements that are subject to many risks and uncertainties. In particular, the outcome and timing of litigation are uncertain. These forward-looking statements are made as of the date of this press release, and BioCardia assumes no obligation to update the forward-looking statements.Families affected by the coronavirus may be unemployed right now, and Legal-Bay is determined to help them obtain their lawsuit settlement loans as soon as possible. The company is running a promotion for plaintiffs who have a pending lawsuit, but need cash now. The promotion will run from today until April 30, 2020, and works like this: Any clients that apply for a lawsuit loan or cash advance and are denied will be eligible to receive a $60 gift card to feed their family in this time of need. If your case is approved for funding, then Legal-Bay will proceed to fund you and you will not be eligible for the gift card.
To apply right now, please go to: http://lawsuitssettlementfunding.com or call 877.571.0405 where live agents are available 24 hours a day to assist you.
Chris Janish, CEO of Legal-Bay commented, "Unfortunately, people with pending lawsuits are already at a low point in their life, and having to deal with unemployment or illness due to Covid-19 is unimaginably difficult. Our 'feed or fund' promotion is geared toward letting plaintiffs know that we are open for business and able to fund them in this dire time. And more importantly, if your case is denied you will not be left out in the cold, as we will be donating a $60 food card to any applicants who are denied legal funding over this period as well."
Legal-Bay has chosen Grubhub and Uber Eats along with other national vendors to assist them during this promotion because they can offer bulk gift cards quickly via email delivery to families in need. Legal-Bay expects to have all gift cards delivered electronically between May 1 and May 15.
The program is designed to add extra incentive to people who are at a particularly difficult time in life, or have been denied funding in the past because they have a prior contract. Legal-Bay is one of the best lawsuit funding companies because they accept applications on almost all lawsuits. They are also the best legal funding company when it comes to large buyouts of prior lawsuit loans, whereas the original funding company has stopped funding. Legal-Bay has a Best Price Guarantee for all their clients, so most times buyout cases can be refinanced at cheaper rates than the existing loan. What this means is that it's possible to get an additional cash payment and yet still maintain the same payback terms. It costs nothing to inquire about refinancing options; the evaluation is free.
Here are just some of the cases that Legal-Bay will consider: Car and truck accidents, discrimination or wrongful termination, medical malpractice, sexual harassment and abuse, nursing home abuse, wrongful imprisonment, police brutality, labor law or construction accidents, Jones Act or maritime law, Fela or train accidents, personal injury, verdict on appeal cases, commercial litigation funding, civil cases involving general negligence, wrongful death, Hernia Mesh, IVC Filters, Round Up, Essure, attorney case cost funding, breach of contract, slip, trip, and falls, premise liability and more.
The application process couldn't be easier, and if your case is approved, you can expect to receive your presettlement money within 24 hours. Plaintiffs are often pressured into settling lawsuits at a much lower sum than what they may actually receive at the trial, but the right funding company can keep this from happening by buying plaintiffs time to obtain a fair settlement. Procuring cash funding in advance of a final ruling can be a valuable tool if used properly. There are no credit checks or out of pocket expenses, and even if you are out of work or unemployed we can help you based on the strength of your case. Many businesses like a Baker operation or people on Street need funding, and can apply regardless of their employment status.
To qualify for the free gift card the following items are contingent:
Again, if your law firm is unable or unwilling to participate in the evaluation process then you will not qualify for the gift card. To learn more, please view CEO Chris Janish's message about the "Feed or Fund" promotion on YouTube by clicking HERE.
Legal-Bay urges anyone that knows a family member in need of coronavirus relief and has a pending lawsuit to forward this information to them immediately. Pre settlement funding will help to lift the burden through this trying time. A simple phone call could change their financial circumstances within a matter of days.
To apply right now, please go to: http://lawsuitssettlementfunding.com or call 877.571.0405 where live agents are available 24 hours a day to assist you. "Legal-Bay is just a call away."
Disclaimer - Legal-Bay's funding programs are non-recourse cash advances, and although many plaintiffs refer to them as loans, they are not a lawsuit loan, lawsuit loans, settlement loan or settlement loans of any kind. The risk-free cash advances are unlike a loan because if you lose your case you do not need to repay the advance.
Eric Blinderman CEO (U.S.) Therium
Ralph Sutton Founder Validity FinancePaul Haskel Partner RK&O
Additional speakers to follow.
The panel discussion will be moderated by Ed Truant, founder of Slingshot Capital, and there will be a Q&A session with audience questions following the panel.
Here is the link to attend: https://www.eventbrite.com/e/